Steve Kraus

Partner

Steve Kraus is a partner at Bessemer in the Cambridge office and a world-renowned healthcare investor. He currently sits on the boards of Welltok, Bright Health, Groups, Qventus, Health Essentials, Docent Health, Alcresta, and is a board observer at Collective Medical Technologies.

Prior to joining Bessemer, Steve worked for a growth-stage, private equity firm as a management consultant at Bain & Company. He has also worked on several different political campaigns throughout his career.

He serves on the board of the New England Venture Capital Association (NEVCA), the Achievement Network, as well as the investment committees of BCBS Massachusetts and Rock Health. He is an innovation advisor to Boston Children’s Hospital and advisor to Harvard Business School’s Center for Entrepreneurship.

Steve graduated summa cum laude from Yale University and earned his MBA from Harvard, where he was a Baker Scholar.

“Innovations in healthcare will have the greatest impact on human life– and it’s just beginning.”

Companies

Acceleron *

Acceleron

NASDAQ: XLRN

Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. Acceleron went public in September 2013 (NASDAQ: XLRN).

Allena Pharmaceuticals *

Allena Pharmaceuticals

NASDAQ: ALNA

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases. Allena Pharmaceuticals went public in November 2017 (NASDAQ: ALNA).

ClearCare *

ClearCare

ClearCare is a cloud-based home care software provider. In 2017, ClearCare was acquired.

Collective Medical

Collective Medical

Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care.

DocuTAP *

DocuTAP

ACQUIRED BY: WARBURG PINCUS

DocuTAP provides urgent care EMR and practice management software for healthcare providers. DocuTAP was acquired by Warburg Pincus in 2016.

Flex Pharma, Inc. *

Flex Pharma, Inc.

NASDAQ: FLKS

Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms. In January 2015, Flex Pharma went public (NASDAQ: FLKS).

Groups

Groups

Groups helps people recover from opiate use through therapy and medication.

Insmed *

Insmed

NASDAQ: INSM

Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. In 2000, Insmed went public (NASDAQ: INSM).

Kymera Therapeutics

Kymera Therapeutics

Kymera Therapeutics is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.

Liazon *

Liazon

ACQUIRED BY: TOWERS WATSON & CO.

Liazon is an online benefits store that operates private benefits exchange for businesses. In November 2013, Liazon was acquired by Towers Watson & Co.

Qventus

Qventus

Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.

Stromedix *

Stromedix

ACQUIRED BY: BIOGEN IDEC.

Stromedix is a biomedical company focused on drugs for fibrosis, organ failure and cancer. In 2012, Stromedix was acquired by Biogen Idec.

Subtle Medical

Subtle Medical

Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.

Verastem *

Verastem

NASDAQ: VSTM

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. In January 2012, Verastem went public (NASDAQ: VSTM).